Display options
Share it on

World J Transplant. 2016 Jun 24;6(2):411-22. doi: 10.5500/wjt.v6.i2.411.

Proposal of new expanded selection criteria using total tumor size and (18)F-fluorodeoxyglucose - positron emission tomography/computed tomography for living donor liver transplantation in patients with hepatocellular carcinoma: The National Cancer Center Korea criteria.

World journal of transplantation

Seung Duk Lee, Bora Lee, Seong Hoon Kim, Jungnam Joo, Seok-Ki Kim, Young-Kyu Kim, Sang-Jae Park

Affiliations

  1. Seung Duk Lee, Seong Hoon Kim, Sang-Jae Park, Center for Liver Cancer, Research Institute and Hospital, National Cancer Center, Goyang 10408, South Korea.

PMID: 27358787 PMCID: PMC4919746 DOI: 10.5500/wjt.v6.i2.411

Abstract

AIM: To expand the living donor liver transplantation (LT) pool of eligible patients with hepatocellular carcinoma (HCC) using new morphological and biological criteria.

METHODS: Patients with HCC who underwent living donor LT (LDLT) from March 2005 to May 2013 at the National Cancer Center Korea (NCCK) were enrolled. We performed the (18)F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) before LDLT. Overall and disease-free survival analysis was done in patients to evaluate the usefulness of new NCCK criteria using PET/CT and total tumor size (10 cm).

RESULTS: We enrolled a total of 280 patients who pathologically confirmed to have HCC and performed the PET/CT before transplantation. Among them, 164 (58.6%) patients fulfilled the NCCK criteria and 132 patients (47.1%) met the Milan criteria. Five-year overall and disease-free survival rates for patients who fulfilled the NCCK criteria showed 85.2% and 84.0%, respectively, and were significantly higher than those beyond the NCCK criteria (60.2% and 44.4%, respectively; P < 0.001). The correlation analysis between preoperative imaging tests and pathologic reports using Cohen's Kappa demonstrated the better results in the NCCK criteria than those in the Milan criteria (0.850 vs 0.583). The comparison of disease-free analysis among the NCCK, Milan, and University of California, San Francisco (UCSF) criteria using the receiver operating characteristics curves revealed the similar area under the curve value criteria (NCCK vs Milan, P = 0.484; NCCK vs UCSF, P = 0.189 at 5-years).

CONCLUSION: The NCCK criteria using hybrid concept of both morphological and biological parameters showed an excellent agreement between preoperative imaging and pathological results, and favorable survival outcomes. These new criteria might select the optimal patients with HCC waiting LDLT and expand the selection pool.

Keywords: Hepatocellular carcinoma; Liver transplantation; Living donor; Selection criteria

References

  1. Liver Transpl. 2001 Jul;7(7):631-6 - PubMed
  2. Dig Dis. 2007;25(4):299-302 - PubMed
  3. Transpl Int. 2013 Jan;26(1):50-60 - PubMed
  4. Am J Transplant. 2010 Sep;10(9):2092-8 - PubMed
  5. Transplantation. 2003 Feb 15;75(3 Suppl):S6-11 - PubMed
  6. Hepatology. 2001 Jun;33(6):1394-403 - PubMed
  7. Liver Transpl. 2006 Aug;12(8):1260-7 - PubMed
  8. Liver Transpl. 2013 Aug;19(8):872-8 - PubMed
  9. Am J Transplant. 2009 Mar;9(3):592-600 - PubMed
  10. Liver Transpl. 2008 Oct;14(10):1449-60 - PubMed
  11. J Surg Oncol. 2007 Mar 1;95(3):235-40 - PubMed
  12. Liver Transpl. 2008 Aug;14 (8):1107-15 - PubMed
  13. Ann Surg. 2007 Mar;245(3):435-42 - PubMed
  14. Ann Surg Oncol. 2008 May;15(5):1375-82 - PubMed
  15. Am J Transplant. 2007 Apr;7(4):972-81 - PubMed
  16. J Nucl Med. 1992 Mar;33(3):333-9 - PubMed
  17. J Gastroenterol Hepatol. 2006 Mar;21(3):572-4 - PubMed
  18. Ann Surg. 2002 Apr;235(4):533-9 - PubMed
  19. Am J Gastroenterol. 2010 Mar;105(3):610-2 - PubMed
  20. J Hepatol. 2008 Oct;49(4):581-8 - PubMed
  21. Dig Dis. 2007;25(4):310-2 - PubMed
  22. Biometrics. 1988 Sep;44(3):837-45 - PubMed
  23. Liver Transpl. 2004 Apr;10(4):534-40 - PubMed
  24. Liver Transpl. 2012 Jan;18(1):53-61 - PubMed
  25. Hepatobiliary Pancreat Dis Int. 2014 Feb;13(1):18-24 - PubMed
  26. Liver Transpl. 2006 Oct;12 (10 ):1504-11 - PubMed
  27. Lancet Oncol. 2009 Jan;10(1):35-43 - PubMed
  28. World J Surg. 2006 Sep;30(9):1736-41 - PubMed
  29. Hepatogastroenterology. 2008 Sep-Oct;55(86-87):1671-7 - PubMed
  30. N Engl J Med. 1996 Mar 14;334(11):693-9 - PubMed
  31. Liver Transpl. 2010 Jun;16(6):767-72 - PubMed
  32. J Hepatobiliary Pancreat Sci. 2010 Sep;17(5):539-47 - PubMed
  33. Liver Transpl. 2007 Mar;13(3):391-9 - PubMed
  34. Transplantation. 2009 Feb 27;87(4):531-7 - PubMed

Publication Types